User:Mvanhoef

Marlies Van Hoef founded Transplant Creations in 2000 and is chief executive. At Transplant Creations she focused on the development, promotion and implementation of reduced intensity conditioning autologous and allogeneic bone marrow derived peripheral blood progenitor cells as part of initial therapy of cancer to support improvement of disease outcome. She has years of practical clinical experience with focus on oncology, hematology and bone marrow stem cell transplantation and years of experience in clinical research and biopharmaceutical product development in these therapeutic areas. She worked internationally and held positions in clinical research in the academical, biopharmaceutical and biotech sector and worked as consultant in product development. She obtained Board Certification in internal medicine, oncology and hematology and holds an MD and PhD from Utrecht University in the Netherlands and an MBA from the Californian Coast University.